hexamethonium has been researched along with Complications of Diabetes Mellitus in 2 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| GRIFFITHS, JA | 1 |
| DALLE COSTE, P | 1 |
| KLINGER, R | 1 |
2 other studies available for hexamethonium and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
The effects of general anaesthesia, and hexamethonium, on the blood-sugar in non-diabetic and diabetic surgical patients.
Topics: Anesthesia; Anesthesia, General; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Hexametho | 1953 |
[Rauwolfia serpentina extracts combined with hexamethonium in therapy of arterial hypertension in diabetics].
Topics: Diabetes Complications; Diabetes Mellitus; Hexamethonium; Hexamethonium Compounds; Humans; Hypertens | 1957 |